* Vera Therapeutics filed a Form 3 naming Nancy Lee Boman as chief regulatory officer.
Back to newsVera Therapeutics names Nancy Lee Boman as chief regulatory officer in initial beneficial ownership filingVVERA•2026-08-05Form 3 filing names chief regulatory officer Vera Therapeutics filed a Form 3 naming Nancy Lee Boman as chief regulatory officer. Related NewsCUS nuclear power plants defeat employees' wage suppression lawsuitCEG•2026-08-05NNutrien misses quarterly profit estimates on weaker potash, nitrogen sales volumesNTR•2026-08-05OBlue Owl Capital Q2 FY26 GAAP net investment income rises to $176.17 million; net asset value per share slips to $14.26OBDC•2026-08-05SourcesSSVera Therapeutics names Nancy Lee Boman as chief regulatory officer in initial beneficial ownership filingSec